To the content
4 . 2017

The place of Diabeton MR in the modern treatment of diabetes mellitus type 2

AbstractFor many years, suLfonyLureas have been the foundation in the treatment of diabetes meLLitus type 2, despite the emergence of new antidiabetic drugs, the addition of suLfonyLureas is stiLL a variant of the second Line of therapy in addition to monotherapy with metformin. The combination of metformin and gLicLazide MR is not onLy effective, but aLso contributes to prevention of deveLopment of diabetic micro- and macrovascuLar compLications, inhibits the deveLopment and progression of nephropathy due to the unique properties and benefits of this drug.

Keywords:gliclazide MR, metformin, diabetes mellitus type 2

Endocrinology: News, Opinions, Training. 2017; (4): 44-51.
DOI: 10.24411/2304-9529-2017-00053


All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»